90 patents
Page 3 of 5
Utility
Foot-and-mouth Disease Vaccine
24 Mar 22
Compositions for prevention of Foot and Mouth Disease (FMD) are provided, comprising an antigen component in the amount equivalent to 0.5-20 μg FMD virus and an adjuvant component comprising oil, an immunostimulatory oligonucleotide, and a polycationic carrier.
Paul Joseph Dominowski, John Morgan Hardham, James Alan Jackson, Cyril Gerard Gay, Luis Leandro Rodriguez, Peter William Krug, Aida Elizabeth Rieder
Filed: 19 Feb 21
Utility
Signal Amplification In Solution-based Plasmonic Specific-binding Partner Assays
17 Mar 22
The present invention relates to analyte detection devices and methods of using such devices to detect minute quantities of a target analyte in a sample.
Rajesh K. MEHRA, Vincent CHIANG, Kenneth ARON, Jessica FRISZ
Filed: 29 Nov 21
Utility
Anthelmintic Laboratory Animal Model for Heartworm
10 Mar 22
The current invention describes a laboratory animal model for dirofilarial nematodes wherein said laboratory animal is fed a dietary admixture of laboratory feed containing an immunosuppressing agent, for example, a glucocorticoid.
Brian John Mills, Tom L. McTier, Christopher S. Knauer, Debra Jean Woods
Filed: 7 Jan 20
Utility
Signal Amplification In Plasmonic Specific-binding Partner Assays
10 Mar 22
The present invention relates to analyte detection devices and methods of using such devices to detect minute quantities of a target analyte in a sample.
Rajesh K. Mehra, Vincent Chiang, Kenneth P. Aron, Asher Krell
Filed: 16 Nov 21
Utility
Palatable Formulations
3 Mar 22
The present invention is directed to a soft chewable composition comprising or containing a therapeutically effective amount of a veterinary active agent, preferably a JAK inhibitor; an animal based palatant, a non-animal based palatant, a flavor modifier, and at least one veterinary acceptable excipient that is selected from at least one each of a disintegrant, binder, lubricant, humectant, and glidant; and wherein the soft chewable tablet is compressed with a rotary tablet press; and methods for treating or preventing cancer, asthma, atopic dermatitis, autoimmune disorders, pruritus associated with allergic dermatitis, allergies, and chronic respiratory disease in an animal.
Paramjit Singh, Debendra Kumar Panda, Jeffrey Ellis Price, Atul Chhagan Badhan, Nicholas Finn Cunningham
Filed: 19 Feb 20
Utility
Lateral Flow Device for Detecting SARS-CoV-2 Antibodies in Human and Animal Samples
17 Feb 22
The invention provides a lateral flow device and methods for the detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a sample of bodily fluid of an animal or human.
Joshua T. Lizer, Jason J. Workman, James P. Gillies, Eric T. Baima, Rajesh K. Mehra
Filed: 30 Jul 21
Utility
Anti-coronavirus Vaccines
17 Feb 22
The invention provides stable coronavirus spike proteins.
Eric Todd Baima, Yulia Burakova, Paul Joseph Dominowski, Steven Alan Dunham, Nicole Lynn Hainer, John Morgan Hardham, Mahesh Kumar, Jason John Millership, Duncan M. Mwangi, Sharath K. Rai, Sharon Marie Wappel, Dennis Lee Foss
Filed: 30 Jul 21
Utility
Cell Line for Production of Marek's Disease Virus Vaccine and Methods of Making and Using the Same
16 Dec 21
The present application relates to an avian cell line capable of supporting viral growth of Marek's Disease Virus (MDV), including Herpes Virus of Turkeys (HVT), methods of producing such cell lines, and therapeutic uses of the cell lines and resulting vaccines.
Keith Allen Ameiss, Everett Lee Rosey
Filed: 14 Jun 21
Utility
Long-acting Spiro-isoxazoline Antiparasitic Compositions
9 Dec 21
Guy Francis de Rose, Nathan Anthony Logan Chubb, Patrick F. M. Meeus, Tom L. McTier
Filed: 3 Aug 21
Utility
Egg Grasp Device Having Interlaced Members, and Associated Systems and Methods
9 Dec 21
An egg grasp device is provided.
William Dongwook Suh
Filed: 24 Aug 21
Utility
Process for Preparing a Novel Phenicol Antibacterial Agent
18 Nov 21
Randall Lee DeJong, Gregory Lee Karrick, Timothy Lee Stuk
Filed: 23 Sep 19
Utility
Novel Adjuvant Compositions
4 Nov 21
This invention relates to adjuvant formulations comprising various combinations of triterpenoids, sterols, immunomodulators, polymers, and Th2 stimulators; methods for making the adjuvant compositions; and the use of the adjuvant formulations in immunogenic and vaccine compositions with different antigens.
Paul Joseph Dominowski, Ramasamy Mannar Mannan, Richard Lee Krebs, James Richard Thompson, Tedd Alan Childers, Mary Kathryn Olsen, Robert John Yancey, JR., Risini Dhammika Weeratna, Shucheng Zhang, Cedo Martin Bagi
Filed: 8 Mar 21
Utility
Immunomodulating Urea Azalides
23 Sep 21
Mark R. Cox, Timothy L. Stuk, Todd M. Maddux, Richard Andrew Ewin, Paul D. Johnson, Tomasz Respondek, Graham M. Kyne, Rajendran Vairagoundar
Filed: 11 Mar 21
Utility
Novel Lyophilization Methods that provide Stably Dehydrated Protozoans for use as Potent Live Vaccines
16 Sep 21
An improved stabilization buffer for use in the lyophilization of Neospora and other protozoans is disclosed.
Rim Daoussi, Frederick H. Weber
Filed: 4 Oct 17
Utility
Methods of Using Smectite Compositions for Treating Clostridium Difficile Associated Diseases and Symptoms
2 Sep 21
Provided herein are compositions useful for the treatment or prevention of C. difficile-associated disease or C. difficile-associated diarrhea in a subject in need thereof, and delivery systems and package systems comprising the same.
Mark HERTHEL, Erin KELLEY, Tara HEMBROOKE, Chase MILLHOLLEN
Filed: 16 Oct 20
Utility
Anti-NGF Antibodies and Methods Thereof
19 Aug 21
The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same.
Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
Filed: 12 Mar 21
Utility
Palatable Antiparasitic Formulations
22 Jul 21
The present invention is directed to a palatable, hard chewable composition comprising a therapeutically effective amount of a veterinary acceptable isoxazoline, a stabilized macrocyclic lactone, an acceptable salt form of pyrantel, at least one natural animal based palatant, and at least one veterinary acceptable excipient; and methods for treating or preventing a parasitic infection or infestation in an animal in need thereof with said composition.
Sachin Pundlik Kolhe, Supriya Gautam Thakur
Filed: 3 Sep 19
Utility
Anti-NGF Antibodies and Methods Thereof
22 Jul 21
The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same.
Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
Filed: 5 Mar 21
Utility
Anti-NGF Antibodies and Methods Thereof
22 Jul 21
The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same.
Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
Filed: 5 Mar 21
Utility
Anti-NGF Antibodies and Methods Thereof
15 Jul 21
The present disclosure encompasses novel anti-NGF antibodies, antigen binding proteins and polynucleotides encoding the same.
Sebastian C. J. Steiniger, William Dunkle, Catherine Rugg, Steven A. Dunham
Filed: 4 Mar 21